Cargando…
Anticoagulation after Transcatheter Aortic Valve Implantation: Current Status
Transcatheter aortic valve implantation (TAVI) is the standard of care for symptomatic severe aortic stenosis. Antithrombotic therapy is required after TAVI to prevent thrombotic complications but it increases the risk of bleeding events. Current clinical guidelines are mostly driven by expert opini...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Radcliffe Cardiology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7203879/ https://www.ncbi.nlm.nih.gov/pubmed/32382318 http://dx.doi.org/10.15420/icr.2019.24 |
_version_ | 1783529954323988480 |
---|---|
author | Greco, Antonio Capodanno, Davide |
author_facet | Greco, Antonio Capodanno, Davide |
author_sort | Greco, Antonio |
collection | PubMed |
description | Transcatheter aortic valve implantation (TAVI) is the standard of care for symptomatic severe aortic stenosis. Antithrombotic therapy is required after TAVI to prevent thrombotic complications but it increases the risk of bleeding events. Current clinical guidelines are mostly driven by expert opinion and therefore yield low-grade recommendations. The optimal antithrombotic regimen following TAVI has yet to be determined and several randomised controlled trials assessing this issue are ongoing. The purpose of this article is to critically explore the impact of antithrombotic drugs, especially anticoagulants, on long-term clinical outcomes following successful TAVI. |
format | Online Article Text |
id | pubmed-7203879 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Radcliffe Cardiology |
record_format | MEDLINE/PubMed |
spelling | pubmed-72038792020-05-07 Anticoagulation after Transcatheter Aortic Valve Implantation: Current Status Greco, Antonio Capodanno, Davide Interv Cardiol Structural Transcatheter aortic valve implantation (TAVI) is the standard of care for symptomatic severe aortic stenosis. Antithrombotic therapy is required after TAVI to prevent thrombotic complications but it increases the risk of bleeding events. Current clinical guidelines are mostly driven by expert opinion and therefore yield low-grade recommendations. The optimal antithrombotic regimen following TAVI has yet to be determined and several randomised controlled trials assessing this issue are ongoing. The purpose of this article is to critically explore the impact of antithrombotic drugs, especially anticoagulants, on long-term clinical outcomes following successful TAVI. Radcliffe Cardiology 2020-04-23 /pmc/articles/PMC7203879/ /pubmed/32382318 http://dx.doi.org/10.15420/icr.2019.24 Text en Copyright © 2020, Radcliffe Cardiology https://creativecommons.org/licenses/by-nc/4.0/legalcode This work is open access under the CC-BY-NC 4.0 License which allows users to copy, redistribute and make derivative works for non-commercial purposes, provided the original work is cited correctly. |
spellingShingle | Structural Greco, Antonio Capodanno, Davide Anticoagulation after Transcatheter Aortic Valve Implantation: Current Status |
title | Anticoagulation after Transcatheter Aortic Valve Implantation: Current Status |
title_full | Anticoagulation after Transcatheter Aortic Valve Implantation: Current Status |
title_fullStr | Anticoagulation after Transcatheter Aortic Valve Implantation: Current Status |
title_full_unstemmed | Anticoagulation after Transcatheter Aortic Valve Implantation: Current Status |
title_short | Anticoagulation after Transcatheter Aortic Valve Implantation: Current Status |
title_sort | anticoagulation after transcatheter aortic valve implantation: current status |
topic | Structural |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7203879/ https://www.ncbi.nlm.nih.gov/pubmed/32382318 http://dx.doi.org/10.15420/icr.2019.24 |
work_keys_str_mv | AT grecoantonio anticoagulationaftertranscatheteraorticvalveimplantationcurrentstatus AT capodannodavide anticoagulationaftertranscatheteraorticvalveimplantationcurrentstatus |